Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies

Harnessing the human immune system as a foundation for therapeutic technologies capable of recognizing and killing tumor cells has been the central objective of anti-cancer immunotherapy. In recent years, there has been an increasing interest in improving the effectiveness and accessibility of this...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganeeva, Irina, Zmievskaya, Ekaterina, Valiullina, Aygul, Kudriaeva, Anna, Miftakhova, Regina, Rybalov, Alexey, Bulatov, Emil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774716/
https://www.ncbi.nlm.nih.gov/pubmed/36551014
http://dx.doi.org/10.3390/bioengineering9120808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774716/
https://www.ncbi.nlm.nih.gov/pubmed/36551014
http://dx.doi.org/10.3390/bioengineering9120808

Ejemplares similares